Exclusive-US weighs allowing most pharma licensing deals with China, sources say

This is a summary. Read the complete story at Investing.com below.

Related Stories

stocksabout 4 hours ago

TSX futures edge higher amid post-midterms stock rotation

Investing.com

stocksabout 4 hours ago

AI, data-center stocks slip as Democratic sweep clouds expansion plans

Investing.com

stocksabout 4 hours ago

Citi raises Novo Nordisk stock target despite ’mixed’ results

Investing.com